For help on how to get the results you want, see our search tips.
21 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Summaries of opinion Remove Summaries of opinion filter
Periodic safety update report single assessments Remove Periodic safety update report single assessments filter
Categories
Human Remove Human filter
Application type
Post-authorisation Remove Post-authorisation filter
Opinion status
Positive Remove Positive filter
-
List item
Summary of opinion: Galvus
vildagliptin, opinion date: 20/05/2021, Positive, Last updated: 21/05/2021 -
List item
Summary of opinion: Jalra
vildagliptin, opinion date: 20/05/2021, Positive, Last updated: 21/05/2021 -
List item
Summary of opinion: Xiliarx
vildagliptin, opinion date: 20/05/2021, Positive, Last updated: 21/05/2021 -
List item
Summary of opinion: Zomarist
vildagliptin, metformin, opinion date: 21/05/2021, Positive, Last updated: 21/05/2021 -
List item
Summary of opinion: Icandra (previously Vildagliptin / metformin hydrochloride Novartis)
vildagliptin, metformin, opinion date: 21/05/2021, Positive, Last updated: 21/05/2021 -
List item
Summary of opinion: Eucreas
vildagliptin, metformin, opinion date: 20/05/2021, Positive, Last updated: 21/05/2021 -
List item
Summary of opinion: Darzalex
daratumumab, opinion date: 20/05/2021, Positive, Last updated: 21/05/2021 -
List item
Summary of opinion: Evotaz
atazanavir, cobicistat, opinion date: 21/05/2021, Positive, Last updated: 21/05/2021 -
List item
Summary of opinion: Galafold
migalastat, opinion date: 24/06/2021, Positive, Last updated: 25/06/2021 -
List item
Summary of opinion: Rinvoq
upadacitinib, opinion date: 24/06/2021, Positive, Last updated: 25/06/2021 -
List item
Summary of opinion: Xeljanz
tofacitinib, opinion date: 24/06/2021, Positive, Last updated: 25/06/2021 -
List item
Summary of opinion: Edistride
dapagliflozin, opinion date: 24/06/2021, Positive, Last updated: 25/06/2021 -
List item
Summary of opinion: Forxiga
dapagliflozin, opinion date: 24/06/2021, Positive, Last updated: 25/06/2021 -
List item
Summary of opinion: Spherox
spheroids of human autologous matrix-associated chondrocytes, opinion date: 20/05/2021, Positive, Last updated: 21/05/2021 -
List item
Summary of opinion: Opdivo
nivolumab, opinion date: 24/06/2021, Positive, Last updated: 25/06/2021 -
List item
Summary of opinion: Keytruda
pembrolizumab, opinion date: 20/05/2021, Positive, Last updated: 21/05/2021 -
List item
Summary of opinion: Volibris (new)
ambrisentan, opinion date: 22/07/2021, Positive, Last updated: 23/07/2021 -
List item
Summary of opinion: Vosevi (new)
sofosbuvir, velpatasvir, voxilaprevi, opinion date: 22/07/2021, Positive, Last updated: 23/07/2021 -
List item
Summary of opinion: Deltyba (new)
delamanid, opinion date: 22/07/2021, Positive, Last updated: 23/07/2021 -
List item
Summary of opinion: Ultomiris (new)
ravulizumab, opinion date: 22/07/2021, Positive, Last updated: 23/07/2021 -
List item
Summary of opinion: Maviret
glecaprevir, pibrentasvir, opinion date: 22/04/2021, Positive, Last updated: 26/04/2021